Extravasation of topotecan, a report of two cases

Journal of Oncology Pharmacy Practice

Volumn 3, Issue 2, 1997, Pages 115-116

  Oostweegel, Lonneke M M ^a   Warmerdam Van, Laurence J C ^a   Schot, Margaret ^a   Dubbelman, Ria C ^a   Huinink Bokkel Ten, Wim W ^a   Beijnen, Jos H ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Adverse effects; Extravasation; Topotecan

Indexed keywords

EID: 0000665757     PISSN: 10781552     EISSN: 1477092X     Source Type: Journal    
DOI: 10.1177/107815529700300205     Document Type: Review

References (12)

1. Gottlieb JA, Guarino AM, Call JB,et al.Preliminary pharmacological and clinical evaluation of camptothecin sodium (NSC 100880). Cancer Chemother Rep. 1970;54:461-470.
2. Hertzberg RP, Caranfa MJ, Holden KG,et al.Modification of the hydroxy lactone ring of camptothecin: Inhibition of mammalian topoisomerase I and biological activity. J Med Chem. 1989;32:715-720.
3. Hertzberg RP, Caranfa MJ, Hecht SM On the mechanism of topoisomerase I inhibition by camptothecin: Evidence for binding to an enzyme-DNA complex. Biochemistry. 1989;28:4629 - 4638.
4. Anonymous. DNA topoisomerases-new twist to tumour therapy. Lancet 1988;i:512-513.
5. Creemers GJ, Lund B., Verweij J. Topoisomerase I inhibitors: Topotecan and irinotecan. Cancer Treatment Rev. 1994;20:73-96.
6. Carmichael J., Gordon A., Malfetano J.,et al.Topotecan, a new active drug, versus paclitaxel in advanced ovarian carcinoma: International study group trial. Proc Am Soc Clin Oncol. 1996;15:283.
7. Van Warmerdam LJC, Verweij J., Schellens JHM,et al.Pharmacokinetics and pharmacodynamics of topotecan administered in a daily times five regimen every three weeks. Cancer Chemother Pharmacol. 1995;35:237-245.
8. Geervliet E., Beijnen JH, Verweij SL,et al.Extravasation of antineoplastic agents. Pharm Weekbl Sci. 1989;124:843- 853.
9. Dorr RT Antidotes to vesicant chemotherapy extravasations. Blood Rev. 1990;4:41-60.
10. Bertelli A., Gozza GB, Forno MG,et al.Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: A prospective clinical study. J Clin Oncol. 1995;13:2851-2855.
11. Gault DT Extravasation injuries. Br J Plastic Surg. 1993;46:91-96.
12. Muggia FM, Chachoua A., Hochster H. Doxorubicin. In: Cvitkovic E, Droz JP, Armand JP,et al,eds. Handbook of Chemotherapy in Clinical Oncology. Jersey, Channel Islands: Scientific Communication International Ltd;1993;277-280.